Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Heinig

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|March 18, 2022
Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplamHeidemarie Kletzl, Hassan Ajmi, Izabela Antys, et al.
Clinical Pharmacology and Therapeutics|August 4, 2021
Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular AtrophyYumi Cleary, Michael Gertz, Paul Grimsey, et al.
Clinical and Translational Science|March 29, 2023
Relative bioavailability and food effect study of an oral suspension of alectinib in healthy volunteers using venipuncture and capillary microsamplingStephanie N Liu, Priya Agarwal, Katja Heinig, et al.
Bioanalysis|October 7, 2015
An ex vivo potency assay to assess active drug levels of a GLP-1 agonistic peptide during preclinical safety studiesMartin Schäfer, Steven Challand, Eginhard Schick, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2012
Determination of dalcetrapib by liquid chromatography-tandem mass spectrometryKatja Heinig, Franz Bucheli, Olaf Kuhlmann, et al.
Pharmaceutical Research|March 26, 2022
Chemical, Analytical and Pharmacokinetic Characterisation of RO7304898, an API Consisting of Two Rapidly Interconverting DiastereoisomersKatja Heinig, Filippo Sladojevich, Jeannine Petrig Schaffland, et al.
Clinical Pharmacokinetics|May 6, 2023
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in ChildrenYumi Cleary, Heidemarie Kletzl, Paul Grimsey, et al.
Pharmacology Research & Perspectives|December 7, 2018
Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organsAgnès Poirier, Marla Weetall, Katja Heinig, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 2021
Addressing Today's Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the <i>SMN2</i> mRNA Splicing Modifier RisdiplamStephen Fowler, Andreas Brink, Yumi Cleary, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2012
Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studiesAgnès Poirier, Sara Belli, Christoph Funk, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|March 18, 2022
Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplamHeidemarie Kletzl, Hassan Ajmi, Izabela Antys, et al.
Clinical Pharmacology and Therapeutics|August 4, 2021
Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular AtrophyYumi Cleary, Michael Gertz, Paul Grimsey, et al.
Clinical and Translational Science|March 29, 2023
Relative bioavailability and food effect study of an oral suspension of alectinib in healthy volunteers using venipuncture and capillary microsamplingStephanie N Liu, Priya Agarwal, Katja Heinig, et al.
Bioanalysis|October 7, 2015
An ex vivo potency assay to assess active drug levels of a GLP-1 agonistic peptide during preclinical safety studiesMartin Schäfer, Steven Challand, Eginhard Schick, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2012
Determination of dalcetrapib by liquid chromatography-tandem mass spectrometryKatja Heinig, Franz Bucheli, Olaf Kuhlmann, et al.
Pharmaceutical Research|March 26, 2022
Chemical, Analytical and Pharmacokinetic Characterisation of RO7304898, an API Consisting of Two Rapidly Interconverting DiastereoisomersKatja Heinig, Filippo Sladojevich, Jeannine Petrig Schaffland, et al.
Clinical Pharmacokinetics|May 6, 2023
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in ChildrenYumi Cleary, Heidemarie Kletzl, Paul Grimsey, et al.
Pharmacology Research & Perspectives|December 7, 2018
Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organsAgnès Poirier, Marla Weetall, Katja Heinig, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 2021
Addressing Today's Absorption, Distribution, Metabolism, and Excretion (ADME) Challenges in the Translation of In Vitro ADME Characteristics to Humans: A Case Study of the <i>SMN2</i> mRNA Splicing Modifier RisdiplamStephen Fowler, Andreas Brink, Yumi Cleary, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2012
Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studiesAgnès Poirier, Sara Belli, Christoph Funk, et al.
Pageof 4